Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward

被引：116

作者：

Felker, G. Michael ^{[2
]}

Pang, Peter S. ^{[3
]}

Adams, Kirkwood F. ^{[4
,5
]}

Cleland, John G. F. ^{[6
]}

Cotter, Gad ^{[7
]}

Dickstein, Kenneth ^{[8
]}

Filippatos, Gerasimos S. ^{[9
]}

Fonarow, Gregg C. ^{[10
]}

Greenberg, Barry H. ^{[11
]}

Hernandez, Adrian F. ^{[12
]}

Khan, Sadiya

Komajda, Michel ^{[13
]}

Konstam, Marvin A. ^{[14
,15
]}

Liu, Peter P. ^{[16
]}

Maggioni, Aldo P. ^{[17
]}

Massie, Barry M. ^{[18
]}

McMurray, John J. ^{[19
]}

Mehra, Mandeep ^{[20
]}

Metra, Marco ^{[21
]}

O'Connell, John ^{[22
]}

O'Connor, Christopher M. ^{[23
]}

Pina, Ileana L. ^{[24
]}

Ponikowski, Piotr ^{[25
]}

Sabbah, Hani N. ^{[26
]}

Teerlink, John R. ^{[27
]}

Udelson, James E. ^{[28
]}

Yancy, Clyde W. ^{[29
]}

Zannad, Faiez ^{[30
]}

Gheorghiade, Mihai ^{[1
]}

机构：

[1] Northwestern Univ, Ctr Cardiovasc Qual & Outcomes, Feinberg Sch Med, Dept Med, 645 N Michigan Ave,Suite 1006, Chicago, IL 60611 USA

[2] Duke Clin Res Inst Durham, Durham, NC USA

[3] Northwestern Univ, Ctr Cardiovasc Qual & Outcomes, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA

[4] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA

[5] Univ N Carolina, Sch Med, Dept Radiol, Chapel Hill, NC 27514 USA

[6] Univ Hull, Dept Cardiol, Castle Hill Hosp, Kingston Upon Hull, Yorks, England

[7] Momentum Res Inc, Durham, NC USA

[8] Univ Bergen, Inst Internal Med, Bergen, Norway

[9] Univ Athens, Hosp Attikon, Athens, Greece

[10] David Geffen UCLA, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA

[11] Univ Calif San Diego, San Diego, CA 92103 USA

[12] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA

[13] Univ Paris 06, AP HP, Paris, France

[14] Tufts Med Ctr, Ctr Cardiovasc, Boston, MA USA

[15] Tufts Univ, Sch Med, Boston, MA 02111 USA

[16] Univ Toronto, Toronto Gen Hosp, Inst Circulatory & Resp Hlth, Canadian Inst Hlth, Toronto, ON M5S 1A1, Canada

[17] ANMCO Res Ctr, Florence, Italy

[18] Univ Calif San Francisco, Div Cardiol, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA

[19] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[20] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

[21] Univ & Civil Hosp Brescia, Dept Expt & Appl Med, Brescia, Italy

[22] Feinberg Sch Med, Div Cardiol, Chicago, IL USA

[23] Duke Univ, Med Ctr, Duke Heart Ctr, Div Clin Pharmacol, Durham, NC 27710 USA

[24] Case Western Reserve Univ, Cleveland, OH 44106 USA

[25] Med Univ, Fac Hlth Sci, Clin Mil Hosp, Wroclaw, Poland

[26] Henry Ford Hosp, Dept Med, Detroit, MI 48202 USA

[27] Vet Affairs Med Ctr, San Francisco, CA 94121 USA

[28] Tufts Med Ctr, Div Cardiol, Boston, MA USA

[29] Baylor Heart & Vasc Inst, Dallas, TX USA

[30] Nancy Univ, Dept Cardiol, Nancy, France

来源：

CIRCULATION-HEART FAILURE | 2010年 / 3卷 / 02期

关键词：

heart failure; patients; trials; acute heart failure; WORSENING RENAL-FUNCTION; IN-HOSPITAL MORTALITY; RANDOMIZED CONTROLLED-TRIALS; CARDIAC TROPONIN-I; END-POINTS; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; FLUID ACCUMULATION; PROGNOSTIC VALUE; OUTCOMES;

D O I：

10.1161/CIRCHEARTFAILURE.109.893222

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：314 / 325

页数：12

共 69 条

[1] Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) [J].

Abraham, William T. ;

Fonarow, Gregg C. ;

Albert, Nancy M. ;

Stough, Wendy Gattis ;

Gheorghiade, Mihai ;

Greenberg, Barry H. ;

O'Connor, Christopher M. ;

Sun, Jie Lena ;

Yancy, Clyde W. ;

Young, James B. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) :347-356

[2] Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF) [J].

Allen, Larry A. ;

Metra, Marco ;

Milo-Cotter, Olga ;

Filippatos, Gerasimos ;

Reisin, Leonardo H. ;

Bensimhon, Daniel R. ;

Gronda, Edoardo G. ;

Colombo, Paolo ;

Felker, G. Michael ;

Cas, Livio Dei ;

Kremastinos, Dimitrios T. ;

O'Connor, Christopher M. ;

Cotter, Gadi ;

Davison, Beth A. ;

Dittrich, Howard C. ;

Velazquez, Eric J. .

JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) :777-784

[3] End Points for Clinical Trials in Acute Heart Failure Syndromes [J].

Allen, Larry A. ;

Hernandez, Adrian F. ;

O'Connor, Christopher M. ;

Felker, G. Michael .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (24) :2248-2258

[4] Acute heart failure syndromes and coronary perfusion [J].

Beohar, Nirat ;

Erdogan, Ata K. ;

Lee, Daniel C. ;

Sabbah, Hani N. ;

Kern, Morton J. ;

Teerlink, John ;

Bonow, Robert O. ;

Gheorghiade, Mihai .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (01) :13-16

[5] Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program [J].

Blair, John E. A. ;

Zannad, Faiez ;

Konstam, Marvin A. ;

Cook, Thomas ;

Traver, Brian ;

Burnett, John C., Jr. ;

Grinfeld, Liliana ;

Krasa, Holly ;

Maggioni, Aldo P. ;

Orlandi, Cesare ;

Swedberg, Karl ;

Udelson, James E. ;

Zimmer, Christopher ;

Gheorghiade, Mihai .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (20) :1640-1648

[6] Risk assessment in drug development for symptomatic indications: A framework for the prospective exclusion of unacceptable cardiovascular risk [J].

Brass, EP ;

Lewis, RJ ;

Lipicky, R ;

Murphy, J ;

Hiatt, WR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (03) :165-172

[7] Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].

Butler, J ;

Forman, DE ;

Abraham, WT ;

Gottlieb, SS ;

Loh, E ;

Massie, BM ;

O'Connor, CM ;

Rich, MW ;

Stevenson, LW ;

Wang, YF ;

Young, JB ;

Krumholz, HM .

AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338

[8] LEFT-VENTRICULAR EJECTION FRACTION MAY NOT BE USEFUL AS AN END-POINT OF THROMBOLYTIC THERAPY COMPARATIVE TRIALS [J].

CALIFF, RM ;

HARRELSONWOODLIEF, L ;

TOPOL, EJ .

CIRCULATION, 1990, 82 (05) :1847-1853

[9] Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE [J].

Cleland, JGF ;

Freemantle, N ;

Coletta, AP ;

Clark, AL .

EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (01) :105-110

[10] Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT [J].

Cleland, John G. F. ;

Coletta, Alison P. ;

Yassin, Ashraf ;

Buga, Laszlo ;

Torabi, Azam ;

Clark, Andrew L. .

EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (12) :1214-1219

← 1 2 3 4 5 6 7 →